eureKARE launches innovation-driven start-up studio in

0
171


eureKARE launches innovation-pushed start-up studio in Monaco to apply artificial biology in tackling vital environmental problems

Luxembourg, Belgium, and Paris, France – 15 November 2022: eureKARE (“the Company”), an modern funding firm for disruptive artificial biology purposes, immediately proclaims the launch of an innovation-driven start-up studio in Monaco, targeted on supporting and housing artificial biology initiatives which intention to deal with the world’s most urgent environmental challenges. This expands eureKARE’s artificial biology studio community – every with a distinct theme – in Europe’s innovation hotspots. The Monaco studio would be the community’s hub for local weather change-focused innovation.

eureKARE’s artificial biology studio mannequin is a novel, versatile method to biotech start-up creation which identifies, selects and nurtures top quality European science to create a singular ecosystem, placing sources and experience behind scientists and ideas to create and develop new corporations.

Alexandre Mouradian, Chairman, Founder, and Chief Executive Officer of eureKARE, commented:By promoting synthetic biology-based strategies, we will see the emergence of novel sustainable solutions and new economic models that will prove invaluable in addressing some of the world’s largest environmental challenges. The excellence of the marine research being conducted in Monaco was a key determinant in selecting Monaco as one of our SynBio start-up hubs. Together with eureKARE’s support and insight, I am excited to see where this will take us.”

The Monaco studio will give attention to nurturing initiatives devoted to higher defend and extra sustainably harness environmental sources. Plastic air pollution is an instance of a vital environmental concern with round 400 million tons of plastic waste occurring yearly. Engineering novel micro-organisms to digest plastic pollution and to synthesize sustainable plastics is likely one of the initiatives anticipated to be supported by eureKARE’s Monaco studio. Another venture below analysis is the usage of artificial biology to allow sure marine organisms to sense the presence of pollution in sea water and set off a bioremediation (decontamination) response.

Serge Pampfer, Chief Science Officer of eureKARE, added:Among the most exciting SynBio start-up projects that are being considered for investment by eureKARE in Monaco, those aimed at developing cutting-edge technologies to better harness and protect our marine resources are going to take center stage. This is due to the growing need to better protect our oceans, coupled with the wide array of disruptive applications SynBio can have in this area.

Ends

About eureKARE

eureKARE is an funding firm targeted on financing and growing artificial biology innovation throughout Europe. Driven by the idea that artificial biology holds the important thing to most of the world’s most urgent well being and environmental challenges, eureKARE’s skilled group is concentrated on harnessing Europe’s untapped management in the sector to construct the businesses of the longer term. eureKARE is championing a brand new mannequin of start-up creation and improvement to create a dynamic ecosystem of early and later stage ventures by its community of biotech studios. eureKARE’s studios act as a bridge between academia and business, serving to to catalyze improvements into corporations with entry to all of the components they should develop, prosper, and convey advantages to society.

Contacts

eureKARE SA
Cátia Dourado, Communications Manager
[email protected]

Consilium Strategic Communications – Media Relations
Amber Fennell, Sukaina Virji, Genevieve Wilson
[email protected]



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here